Table 1.
Characteristic | Symptomatic, microscopic (n = 57) | Asymptomatic, microscopic (n = 18) | Asymptomatic, sub-microscopic (n = 30) | Overall (N = 105) |
---|---|---|---|---|
Gender, n (%) | ||||
Female | 25 (44) | 8 (44) | 12 (40) | 45 (43) |
Male | 32 (56) | 10 (56) | 18 (60) | 60 (57) |
Parasite density, parasites/μL; median (IQR) | 2,700 (772–5,320)* | 131.5 (63–326.5)* | 7.76 (3.23–14.43)† | 1,570 (143–4,054) |
Gametocyte density, gametocytes/μL; median (IQR) | 448 (120–669) | 24 (3–48) | – | 352 (36– 618) |
No. of infectious individuals | 44 | 4 | 0 | 48 |
Total oocysts/infected mosquito, median (IQR) | 211 (32.25–1,098.25) | 5 (4.25–15.50) | 0 (0–0) | 167.5 (22.25–988) |
Mosquito infection prevalence,‡ %; median (IQR) | 76 (40–91.19) | 7.22 (5.4–19.16) | 0 (0–0) | 74.75 (33.52–90.28) |
Intensity of infection, mean ± SD | 22.14 ± 29.96 | 0.65 ± 1.13 | 0 | 20.35 ± 29.28 |
Parasite density in symptomatic and asymptomatic microscopic groups was calculated with microscopy only.
Parasite density in the symptomatic sub-microscopic group was quantified using quantitative polymerase chain reaction methods, but we could not differentiate sexual stage from asexual stage.
Mosquito infection prevalence calculated for positive infections only.